NL6811676A - - Google Patents

Info

Publication number
NL6811676A
NL6811676A NL6811676A NL6811676A NL6811676A NL 6811676 A NL6811676 A NL 6811676A NL 6811676 A NL6811676 A NL 6811676A NL 6811676 A NL6811676 A NL 6811676A NL 6811676 A NL6811676 A NL 6811676A
Authority
NL
Netherlands
Application number
NL6811676A
Other versions
NL154740B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6811676A publication Critical patent/NL6811676A/xx
Publication of NL154740B publication Critical patent/NL154740B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL686811676A 1967-08-18 1968-08-16 Werkwijze voor het bereiden van een derivaat van 7-(2-amino-2-fenylacetylamino) cefalosporanzuur, werkwijze voor het bereiden van een geneesmiddel met antibacteriele eigenschappen, alsmede een aldus verkregen gevormd geneesmiddel. NL154740B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66152067A 1967-08-18 1967-08-18

Publications (2)

Publication Number Publication Date
NL6811676A true NL6811676A (de) 1969-02-20
NL154740B NL154740B (nl) 1977-10-17

Family

ID=24653945

Family Applications (1)

Application Number Title Priority Date Filing Date
NL686811676A NL154740B (nl) 1967-08-18 1968-08-16 Werkwijze voor het bereiden van een derivaat van 7-(2-amino-2-fenylacetylamino) cefalosporanzuur, werkwijze voor het bereiden van een geneesmiddel met antibacteriele eigenschappen, alsmede een aldus verkregen gevormd geneesmiddel.

Country Status (8)

Country Link
US (1) US3464985A (de)
BE (1) BE719594A (de)
CH (1) CH505854A (de)
DE (1) DE1795151C3 (de)
FR (2) FR7996M (de)
GB (4) GB1247711A (de)
IL (1) IL30546A (de)
NL (1) NL154740B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714146A (en) * 1970-10-05 1973-01-30 Bristol Myers Co Novel syntheses of cephalexin and intermediates therefor
US4007173A (en) * 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
US4018921A (en) * 1973-08-01 1977-04-19 Smithkline Corporation Substituted phenylglycylcephalosporins
US4022895A (en) * 1973-08-01 1977-05-10 Smithkline Corporation Substituted phenylglycylcephalosporins
US3931160A (en) * 1974-05-15 1976-01-06 Smithkline Corporation α-Amino-α-(acylamidophenyl)acetamidocephalosporins
US4111981A (en) * 1975-12-15 1978-09-05 Smithkline Corporation Intermediates for preparing substituted phenylglycylcephalosporins
DE2836613A1 (de) * 1978-08-22 1980-03-13 Bayer Ag Alpha -aminophenylessigsaeurederivate
WO2016063246A1 (en) * 2014-10-22 2016-04-28 Sun Pharmaceutical Industries Limited Crystalline form r of tedizolid phosphate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311621A (en) * 1966-04-07 1967-03-28 Bristol Myers Co Derivatives of cephalosporanic acid

Also Published As

Publication number Publication date
GB1247714A (en) 1971-09-29
FR1603727A (de) 1971-05-24
DE1795151C3 (de) 1975-04-24
CH505854A (de) 1971-04-15
NL154740B (nl) 1977-10-17
GB1247711A (en) 1971-09-29
IL30546A (en) 1972-02-29
GB1247713A (en) 1971-09-29
US3464985A (en) 1969-09-02
BE719594A (de) 1969-02-17
DE1795151A1 (de) 1972-03-23
IL30546A0 (en) 1968-10-24
GB1247712A (en) 1971-09-29
DE1795151B2 (de) 1974-08-29
FR7996M (de) 1970-06-08

Similar Documents

Publication Publication Date Title
AT298283B (de)
FR7572M (de)
AU2277767A (de)
AU1273466A (de)
BE709122A (de)
AU1868267A (de)
BE710760A (de)
BE699960A (de)
BE710686A (de)
BE710656A (de)
BE710514A (de)
BE710306A (de)
BE710144A (de)
BE709921A (de)
BE709919A (de)
BE709796A (de)
BE709664A (de)
BE709647A (de)
BE709583A (de)
BE692922A (de)
BE709150A (de)
AU2406369A (de)
BE708763A (de)
BE705395A (de)
NL6811676A (de)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application